ARIAD Pharmaceuticals
FDA inspection history in Cambridge, Massachusetts, 2017
- 1
- Form 483
Every document, by year
- Form 483
2017: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2017One Form 483, at Cambridge, Massachusetts.
Cited most
Across all ARIAD Pharmaceuticals observations on file
- 21 CFR 314.80Postmarketing reporting of adverse drug experiences1
- 21 CFR 314.81Other postmarketing reports1
The complete ARIAD Pharmaceuticals file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Cambridge, Massachusetts
One Form 483 · 2017 · 2 observations
Latest: Form 483, May 31, 2017 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2017-05-31 | 483 Form 483 | Cambridge, Massachusetts | 2 | $99 |
Investigators on these documents
Erik W. Koester (1)John P. Mistler (1)Victoria M. Daddeo (1)
FEI number 1000513233 · most recent document May 31, 2017
About ARIAD Pharmaceuticals
How many FDA Form 483s has ARIAD Pharmaceuticals received?
FDA Intel has 1 Form 483 on file for ARIAD Pharmaceuticals; the most recent is dated May 31, 2017.
When was ARIAD Pharmaceuticals last inspected by FDA?
The most recent FDA inspection document on file for ARIAD Pharmaceuticals is a Form 483 dated May 31, 2017, for the site in Cambridge, Massachusetts.
What did FDA cite at ARIAD Pharmaceuticals?
The regulations cited most in the observations on file for ARIAD Pharmaceuticals are 21 CFR 314.80 (Postmarketing reporting of adverse drug experiences), 1 time; 21 CFR 314.81 (Other postmarketing reports), 1 time.